Skip to Main Content

Author Details

Kathleen A Cooney
Duke University School of Medicine, and the Duke Cancer Institute
1982
191
50
PMIDPaper TitleJournal TitlePublished Year
36207779Initial outcomes and insights from a novel high-risk prostate cancer screening clinic.Prostate2023
36207779Initial outcomes and insights from a novel high-risk prostate cancer screening clinic.Prostate2023
36567534Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry.Prostate2023
36610816Clinician interest in clinical decision support for PSA-based prostate cancer screening.Urol Oncol2023
36610816Clinician interest in clinical decision support for PSA-based prostate cancer screening.Urol Oncol2023
36567534Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry.Prostate2023
34799695The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients.Br J Cancer2022
35521847Importance of documenting euthanasia decision-making processes in patients' medical records.Vet Rec2022
36353656Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations.Eur Urol Open Sci2022
36446039Germline Variants in DNA Damage Repair Genes and <i>HOXB13</i> Among Black Patients With Early-Onset Prostate Cancer.JCO Precis Oncol2022
34799695The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients.Br J Cancer2022
34674288Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis.Prostate2022
35149774KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression.Prostate Cancer Prostatic Dis2022
35521847Importance of documenting euthanasia decision-making processes in patients' medical records.Vet Rec2022
36446039Germline Variants in DNA Damage Repair Genes and <i>HOXB13</i> Among Black Patients With Early-Onset Prostate Cancer.JCO Precis Oncol2022
36353656Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations.Eur Urol Open Sci2022
35149774KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression.Prostate Cancer Prostatic Dis2022
34674288Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis.Prostate2022
32800727Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.Eur Urol2021
33538481"Sheroes": Celebrating Women in Medicine Month During the Time of COVID-19.Acad Med2021
34210485Prostate Cancer Predisposition.Urol Clin North Am2021
34254341Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.Prostate2021
33257031Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.Eur Urol2021
32800727Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.Eur Urol2021
33383233Pet Owners' Expectations for Pet End-of-Life Support and After-Death Body Care: Exploration and Practical Applications.Top Companion Anim Med2021
34678156A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.Lancet Oncol2021
34757922The use of intrarenal injection of sodium pentobarbital for euthanasia in cats.Am J Vet Res2021
33538481"Sheroes": Celebrating Women in Medicine Month During the Time of COVID-19.Acad Med2021
34757922The use of intrarenal injection of sodium pentobarbital for euthanasia in cats.Am J Vet Res2021
34678156A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.Lancet Oncol2021
34210485Prostate Cancer Predisposition.Urol Clin North Am2021
34254341Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.Prostate2021
33257031Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.Eur Urol2021
33383233Pet Owners' Expectations for Pet End-of-Life Support and After-Death Body Care: Exploration and Practical Applications.Top Companion Anim Med2021
32516092Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.J Clin Oncol2020
31688568Provider Practice Competition and Adoption of Medicare's Oncology Care Model.Med Care2020
32361642Factors associated with appropriate and low-value PSA testing.Cancer Epidemiol2020
31948886Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer.Eur Urol Oncol2020
32409115A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.Eur Urol2020
32299729Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer.Clin Genitourin Cancer2020
32208047Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.J Clin Oncol2020
32923906Pathogenic Germline DNA Repair Gene and <i>HOXB13</i> Mutations in Men With Metastatic Prostate Cancer.JCO Precis Oncol2020
32516092Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.J Clin Oncol2020
32830201Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank.Br J Cancer2020
31688568Provider Practice Competition and Adoption of Medicare's Oncology Care Model.Med Care2020
31948886Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer.Eur Urol Oncol2020
32830201Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank.Br J Cancer2020
32923906Pathogenic Germline DNA Repair Gene and <i>HOXB13</i> Mutations in Men With Metastatic Prostate Cancer.JCO Precis Oncol2020
32361642Factors associated with appropriate and low-value PSA testing.Cancer Epidemiol2020
32208047Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.J Clin Oncol2020
  • 1 - 50 of 382

Recommended Authors

Travis Gerke
The Prostate Cancer Clinical Trials Consortium
Career Start Year 2014
Number of shared co-authors 33
Mahbubl Ahmed
University College London Hospitals NHS Foundation Trust
Career Start Year 2014
Number of shared co-authors 54
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 18
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 36
Mine S Cicek
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 26
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 44
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 48
Hugues Sicotte
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 16
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 29
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 28
Franklin W Huang
Institute for Human Genetics, University of California san francisco
Career Start Year 1998
Number of shared co-authors 41
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 28
Rebecca Sutphen
College of Medicine, University of South Florida
Career Start Year 1995
Number of shared co-authors 32
Carolyn M Hutter
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 29
Montserrat Garcia-Closas
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 48
Carmen Rodriguez
Institut de Recherche en Cancerologie de Montpellier
Career Start Year 1993
Number of shared co-authors 18
Kathleen E Houlahan
University of California los angeles
Career Start Year 1991
Number of shared co-authors 11
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 16
Clare Turnbull
Institute of Cancer Research
Career Start Year 1991
Number of shared co-authors 34
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 5
Jeffery P Struewing
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1988
Number of shared co-authors 17
Wendy S Rubinstein
CancerLinQ LLC, American Society of Clinical Oncology
Career Start Year 1987
Number of shared co-authors 30
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1987
Number of shared co-authors 68
Christopher I Amos
Baylor College of Medicine
Career Start Year 1986
Number of shared co-authors 68
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year 1986
Number of shared co-authors 55
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 38
Heather Thorne
Peter MacCallum Cancer Centre
Career Start Year 1982
Number of shared co-authors 26
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1982
Number of shared co-authors 40
David E Goldgar
University of Utah
Career Start Year 1980
Number of shared co-authors 53
Gloria M Petersen
Mayo Clinic
Career Start Year 1979
Number of shared co-authors 37

Collaborators

William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 51
Ethan M Lange
Co-authored papers 46
Jianfeng Xu
Co-authored papers 46
Elaine A Ostrander
National Cancer Institute
Co-authored papers 27
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 26
Stephen N Thibodeau
Mayo Clinic
Co-authored papers 26
Shannon K McDonnell
Mayo Clinic
Co-authored papers 24
Daniel J Schaid
Mayo Clinic
Co-authored papers 23
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 22
Johanna Schleutker
Institute of Biomedicine, University of Turku
Co-authored papers 22
Fredrik Wiklund
Co-authored papers 20
Graham G Giles
Co-authored papers 19
John D Carpten
Co-authored papers 17
Douglas F Easton
University of Cambridge
Co-authored papers 17
Henrik Gr??nberg
Karolinska Institute
Co-authored papers 16
William D Foulkes
Segal Cancer Centre, Jewish General Hospital
Co-authored papers 16
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 15
Alice S Whittemore
Co-authored papers 15
Christopher A Haiman
University of Southern California
Co-authored papers 11
Sue A Ingles
Co-authored papers 11
David C Smith
Rogel Comprehensive Cancer Center, University of Michigan ann arbor
Co-authored papers 11
Brian E Henderson
University of Southern California
Co-authored papers 10
Ingrid Oakley-Girvan
Co-authored papers 10
Esther M John
Co-authored papers 10
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 9
Timothy R Rebbeck
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 9
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 8
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 8
Maha Hussain
Northwestern University
Co-authored papers 8
Suzanne Kolb
Fred Hutchinson Cancer Research Center
Co-authored papers 7
Release 1.2